Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 78.15
-1.00 (-1.26%)
Oct 20, 2025, 2:45 PM CET
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.37 billion as of October 20, 2025. Its market cap has increased by 63.15% in one year.
Market Cap
1.37B
Enterprise Value
1.30B
Revenue
189.27M
Ranking
n/a
PE Ratio
32.69
Stock Price
€78.15
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.37B, a decrease of -23.66%. That is a compound annual growth rate of -2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.37B | -1.12% |
| Dec 31, 2024 | 1.39B | 88.09% |
| Dec 29, 2023 | 738.49M | -36.23% |
| Dec 30, 2022 | 1.16B | 12.13% |
| Dec 30, 2021 | 1.03B | -21.36% |
| Dec 31, 2020 | 1.31B | 66.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Nov 2, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.13B |
| Laboratorios Farmaceuticos Rovi | 3.07B |
| Almirall | 2.60B |
| Faes Farma | 1.39B |
| Clínica Baviera | 680.43M |
| Oryzon Genomics | 265.74M |
| Atrys Health | 254.18M |
| Laboratorio Reig Jofre | 243.36M |